A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease
- First Online:
- 242 Downloads
Olfactory function is diminished in patients with idiopathic Parkinson disease (IPD). Because previous work almost exclusively relied upon cross-sectional studies, the present investigation aimed to address the correlation between olfactory loss and duration of disease within the context of a longitudinal study, accompanying well-diagnosed patients over an average period of 4.4 years. A group of 27 IPD patients was examined (5 women, 22 men; age range 27–64 years; duration of disease: 0 to 19 years). Psychophysical olfactory testing was performed after 3–6 years (mean 4.4 years) using the "Sniffin’ Sticks" test battery which consists of subtests for odor thresholds, odor discrimination, and odor identification. The study yielded the following major results: (1) olfactory function in IPD patients changes in an unpredictable manner, (2) especially when considering results from the second session relatively few IPD patients were completely anosmic; none of the patients, however, were normosmic. One possible explanation for these findings may lie in the hypothesis based on results by Huisman et al. (2004) who reported an increase of dopaminergic neurons in the olfactory bulb in IPD patients. In this scenario, olfactory loss seen early in the disease may be based on an incomplete inhibition of olfactory input at the level of the olfactory bulb.
Key wordssmell olfaction neurodegeneration
Unable to display preview. Download preview PDF.
- 5.Doty RL, Laing DG (2003) Psychophysical measurement of human olfactory function, including odorant mixture assessment. In: Doty RL (ed) Handbook of olfaction and gustation, 2nd Ed. Marcel Dekker, New York, pp 203–228Google Scholar
- 9.Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H (2007) Olfactory loss may be a first sign of idiopathic Parkinson's disease. Mov Disorders Mar 13; [Epub ahead of print]Google Scholar
- 13.Hummel T (1999) Olfactory evoked potentials as a tool to measure progression of Parkinson's Disease. In: Chase T, Bedard P (eds) Focus on Medicine Vol. 14 – New developments in the drug therapy of Parkinson’s disease. Blackwell Science, Oxford, pp 47–53Google Scholar
- 15.Kobal G, Klimek L, Wolfensberger M, Gudziol H, Temmel A, Owen CM, Seeber H, Pauli E, Hummel T (2000) Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arch Otorhinolaryngol 257:205–211PubMedCrossRefGoogle Scholar
- 24.Westermann B, Wattendorf E, Schwerdtfeger U, Husner A, Fuhr P, Gratzl O, Wolfensberger M, Hummel T, Bilecen D, Welge-Lüssen A (2007) Functional modulation of cortical olfactory pathways in Parkinson's disease: An fMRI study. J Neurol Neurosurg Psychiatry May 22 (Epub ahead of print)Google Scholar